Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Kaul, Dhananjay K ^a   Liu, Xiao Du ^a   Choong, Stephana ^b   Belcher, John D ^b   Vercellotti, Gregory M ^b   Hebbel, Robert P ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antioxidants; Endothelium; Sickle cell anemia; Sulfasalazine

Indexed keywords

ALLOPURINOL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CATALASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZING AGENT; SALAZOSULFAPYRIDINE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; INFLAMMATION; LEUKOCYTE ADHERENCE; MICROCIRCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; SICKLE CELL ANEMIA; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; CONSTRICTION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; HEMATOCRIT; HEMODYNAMIC PROCESSES; LEUKOCYTE COUNT; LEUKOCYTE ROLLING; LEUKOCYTES; MICE; MICE, TRANSGENIC; MICROCIRCULATION; NF-KAPPA B; OXIDANTS; SULFASALAZINE; VASCULAR DISEASES;

EID: 3042621306     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01150.2003     Document Type: Article

References (42)

1. Akgur FM, Brown MF, Zibari GB, McDonald JC, Epstein CJ, Ross CR, and Granger DN. Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol 279: H791-H797, 2000.
2. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, and Freeman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 98: 15215-15220, 2001.
3. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5: 384-394, 1973.
4. Baker M and Wayland H. On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 7: 131-143, 1974.
5. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine 50: 97-112, 1971.
6. Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, and Vercellotti GM. Transgenic sickle mice have vascular inflammation. Blood 2003.
7. Chen D and Kaul DK. Rheologic and hemodynamic characteristics of red cells of mouse, rat and human. Biorheology 31: 103-113, 1994.
8. Childs EW, Udobi KF, Wood JG, Hunter FA, Smalley DM, and Cheung LY. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. Shock 18: 423-427, 2002.
9. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 9: 899-909, 1995.
10. Conger JD and Weil JV. Abnormal vascular function following ischemia-reperfusion injury. J Investig Med 43: 431-442, 1995.
11. Dacie JV and Lewis SM. Practical Hematology. Edinburgh, UK: Churchill Livingstone, 1975.
12. Deryckere F and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16: 405, 1994.
13. S- and α-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci USA 89: 12150-12154, 1992.
14. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 6: 167-178, 1999.
15. Grisham MB, Granger DN, and Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 25: 404-433, 1998.
16. Gute DC, Ishida T, Yarimizu K, and Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179: 169-187, 1998.
17. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, and Freeman BA. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 274: 4985-4994, 1999.
18. Jeon BR, Yeom DH, and Lee SM. Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver. Shock 15: 112-117, 2001.
19. Kaul DK, Fabry ME, Costantini F, Rubin EM, and Nagel RL. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 96: 2845-2853, 1995.
20. Kaul DK and Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106: 411-420, 2000.
21. Klug PP, Kaye N, and Jensen WN. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 8: 175-184, 1982.
22. Kurose I, Argenbright LW, Wolf R, and Granger DN. Oxidative stress during platelet-activating factor-induced microvascular dysfunction. Microcirculation 3: 401-410, 1996.
23. Kurose I, Argenbright LW, Wolf R, Lianxi L, and Granger DN. Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. Am J Physiol Heart Circ Physiol 272: H2976-H2982, 1997.
24. Lachant NA and Oseas RS. Case report: vaso-occlusive crisis associated neutrophil dysfunction in patients with sickle cell disease. Am J Med Sci 294: 253-257, 1985.
25. Lipowsky HH, Usami S, and Chien S. In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat. Microvasc Res 19: 297-319, 1980.
26. Menger MD, Steiner D, and Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow." Am J Physiol Heart Circ Physiol 263: H1892-H1900, 1992.
27. Morita Y, Clemens MG, Miller LS, Rangan U, Kondo S, Miyasaka M, Yoshikawa T, and Bulkley GB. Reactive oxidants mediate TNF-α-induced leukocyte adhesion to rat mesenteric venular endothelium. Am J Physiol Heart Circ Physiol 269: H1833-H1842, 1995.
28. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, and Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96: 314-320, 2000.
29. Platt OS. Sickle cell anemia as an inflammatory disease. J Clin Invest 106: 337-338, 2000.
30. Riaz AA, Wan MX, Schafer T, Dawson P, Menger MD, Jeppsson B, and Thorlacius H. Allopurinol and superoxide dismutase protect against leucocyte-endothelium interactions in a novel model of colonic ischaemia-reperfusion. Br J Surg 89: 1572-1580, 2002.
31. Seki J and Lipowsky HH. In vivo and in vitro measurements of red cell velocity under epifluorescence microscopy. Microvasc Res 38: 110-124, 1989.
32. Silva J and Intaglietta M. The correlation of photometric signals derived from in vivo red blood cell flow in microvessels. Microvasc Res 7: 156-169, 1974.
33. Solovey A, Gui L, Key NS, and Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 101: 1899-1904, 1998.
34. Solovey A, Gui L, Ramakrishnan S, Steinberg MH, and Hebbel RP. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood 93: 3824-3830, 1999.
35. Solovey A, Lin Y, Browne P, Choong S, Wayner E, and Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337: 1584-1590, 1997.
36. Solovey AA, Solovey AN, Harkness J, and Hebbel RP. Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood 97: 1937-1941, 2001.
37. Sowemimo-Coker SO, Meiselman HJ, and Francis RB Jr. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31: 263-265, 1989.
38. Turhan A, Weiss LA, Mohandas N, Coller BS, and Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA 99: 3047-3051, 2002.
39. 2- integrins in vivo. Proc Natl Acad Sci USA 88: 7538-7542, 1991.
40. Wahl C, Liptay S, Adlar G, and Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor κB. J Clin Invest 101: 1163-1174, 1998.
41. Wayland H and Johnson PC. Erythrocyte velocity measurement in microvessels by a two-slit photometric method. J Appl Physiol 22: 333-337, 1967.
42. Weber CK, Liptay S, Wirth T, Adler G, and Schmid RM. Suppression of NF-κB activity by sulfasalazine by direct inhibition of IκB kinases α and β. Gastroenterology 119: 1209-1218, 2000.